Abstract: A load sensor includes: an electrically-conductive elastic body; an electrically-conductive member having a linear shape and disposed so as to cross the electrically-conductive elastic body; and a dielectric body disposed between the electrically-conductive elastic body and the electrically-conductive member. A width of the electrically-conductive elastic body in a longitudinal direction of the electrically-conductive member is changed such that a relationship between a load and a contact area between the electrically-conductive elastic body and the electrically-conductive member via the dielectric body becomes close to a linear relationship.

Abstract: Provided is an antibody that binds to the N-protein of SARS-CoV-2, and a method for utilizing the antibody.

Abstract: A recording apparatus includes a conveyance unit that conveys a recording medium in a first direction toward a recording head for ejecting a liquid, a tank including a containing chamber containing the liquid to be supplied to the recording head, and an injection port through which the liquid is injected into the containing chamber, the tank being disposed downstream of the conveyance unit in the first direction, a rotatable lever that holds a tank cap for closing the injection port, and a cover that rotates about a rotation shaft between an open position for exposing the lever and a closed position for covering the lever, the rotation shaft being disposed upstream of the conveyance unit in the first direction. The cover includes a sliding portion that is provided on a surface facing the lever and comes into contact with the lever while the cover is rotating toward the closed position.

Abstract: A recording apparatus includes a tank including a chamber configured to store liquid to be supplied to a recording head that ejects the liquid and a filling port from which the liquid is injected into the chamber, and an injection auxiliary member configured to assist injecting of the liquid into the chamber from the filling port, the injection auxiliary member including a first and a second flow channels each defined by a first or a second upper end portion that opens toward outside of the tank and a first or a second lower end portion that opens toward inside of the tank, wherein the second flow channel has an expansion portion arranged in a middle portion between the second upper end portion and the second lower end portion and configured to form a step to expand a cross-sectional area.

Abstract: A load sensor is configured to detect, as change in capacitance, change, in a contact area between an electrically-conductive elastic body and a dielectric body, that occurs due to a load applied to an upper face of the load sensor. In the load sensor, a plurality of sensor parts each configured to detect the load are disposed so as to be arranged in a plane direction, and a buffer part configured to suppress displacement of the upper face due to the load applied to a first sensor part from being propagated to a second sensor part adjacent to the first sensor part is disposed between the first sensor part and the second sensor part.

Abstract: A peptide which binds to SARS-CoV-2 and its usage are provided. The peptide which binds to SARS-CoV-2 comprises one or more structural domain comprising CDR3 consisting of an amino acid sequence of any of SEQ ID NOs: 1 to 9 or an amino acid sequence obtained by substituting at least one amino acid in the amino acid sequence with another amino acid.

Abstract: A metastable austenite stainless steel strip of high strength and ductility. The steel strip including C: 0.05 to 0.15%, Si: 0.05 to 1%, Mn: 2% or less, Cr: 16 to 18%, Ni: 4 to 11%, Mo: 2.5 to 3.5%, Cu: 0.4 to 1.0% with a remaining part of Fe, a dual phase structure of an ?? phase and a ? phase where the ? phase is composed of a ?T phase and a ?R phase, a sum of the ?T phase and the ?R phase is 15 to 50 volume %, and a ?T phase area ratio defined by formula (2) (=100×(total area ratio of ?T phase of entire observation area)) is between 1% and 20% inclusive, and 0.2% yield strength (YS) of 1400 N/mm2 to 1900 N/mm2 where a value of YS-EL balance satisfies at least 21,000 to 48,000.

Abstract: A P2X4 receptor antagonist such as paroxetine, a diazepinedione derivative having the following formula (IX) is used as an agent for preventing or treating zoster-associated pain in acute phase: wherein R1 is hydrogen, a C1-8 alkyl group, or the like; each of R2 and R3 is hydrogen, a C1-8 alkyl group, or the like; each of R4 and R5 is hydrogen or the like; and W is a five-membered or six-membered heterocyclic ring optionally having one or more substituents and comprising one to four nitrogen atoms as the members of the ring.

Abstract: A P2X4 receptor antagonist such as paroxetine, a diazepinedione derivative having the following formula (IX) is used as an agent for preventing or treating zoster-associated pain in acute phase: wherein R1 is hydrogen, a C1-8 alkyl group, or the like; each of R2 and R3 is hydrogen, a C1-8 alkyl group, or the like; each of R4 and R5 is hydrogen or the like; and W is a five-membered or six-membered heterocyclic ring optionally having one or more substituents and comprising one to four nitrogen atoms as the members of the ring.

Abstract: A P2X4 receptor antagonist such as paroxetine, a diazepinedione derivative having the following formula (IX) is used as an agent for preventing or treating zoster-associated pain in acute phase: wherein R1 is hydrogen, a C1-8 alkyl group, or the like; each of R2 and R3 is hydrogen, a C1-8 alkyl group, or the like; each of R4 and R5 is hydrogen or the like; and W is a five-membered or six-membered heterocyclic ring optionally having one or more substituents and comprising one to four nitrogen atoms as the members of the ring.

Abstract: A P2X4 receptor antagonist such as paroxetine, a diazepinedione derivative having the following formula (IX) is used as an agent for preventing or treating zoster-associated pain in acute phase: wherein R1 is hydrogen, a C1-8 alkyl group, or the like; each of R2 and R3 is hydrogen, a C1-8 alkyl group, or the like; each of R4 and R5 is hydrogen or the like; and W is a five-membered or six-membered heterocyclic ring optionally having one or more substituents and comprising one to four nitrogen atoms as the members of the ring.